Related Experiment Video
Updated: Sep 28, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Vancomycin tolerance induced by erythromycin but not by loss of vncRS, vex3, or pep27 function in Streptococcus
Gregory T Robertson1, Jingyong Zhao, Bhushan V Desai
1Infectious Diseases Research Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Abstract:
Vancomycin-tolerant Streptococcus pneumoniae is a growing problem among drug-resistant human pathogens. Some vancomycin-tolerant pneumococci have been reported to carry mutations in loci encoding a two-component regulatory system designated VncRS or in a proximal ABC transporter, Vex. A model was advanced proposing that the tolerance phenotype resulted from the inability of a vncS mutant to respond to the Vex-transported Pep27 "death peptide" signal and dephosphorylate VncR, thereby preventing relief of repression of autolytic and other cell death functions in response to antibiotics. To explore this hypothesis, we constructed mutations in vncS, vncR, vex3, and pep27 in S. pneumoniae strain R6 and two additional genetic backgrounds. The lytic responses of the isogenic DeltavncS, Deltavex3, DeltavncR, and Deltapep27 mutants, but not a DeltalytA strain, to vancomycin were indistinguishable from that of the parent strain. DeltavncS strains also failed to exhibit tolerance to vancomycin at various doses in multiple media and showed wild-type sensitivity to other classes of autolysis-inducing antibiotics. In contrast, addition of subinhibitory levels of the antibiotic erythromycin led to tolerance to vancomycin during late, but not early, exponential-phase growth in a DeltavncS strain, in the parent strain R6, and in two other strains bearing erythromycin resistance markers, namely, a DeltavncR strain and an unrelated DeltacomD strain that is defective in competence-quorum sensing. Thus, this tolerance effect resulted from changes in cell growth or other erythromycin-dependent phenomena and not inactivation of vncS per se. Consistent with these results, and in contrast to a previous report, we found that a synthetic form of Pep27 did not elicit lytic or nonlytic killing of pneumococci. Finally, microarray transcriptional analysis and beta-galactosidase reporter assays revealed VncS-dependent regulation of the vex123 gene cluster but did not support a role for VncRS in the regulation of autolytic or other putative cell death loci. Based on these findings, we propose that vancomycin tolerance in S. pneumoniae does not result from loss of vncS function alone.
Insights
Vancomycin tolerance in Streptococcus pneumoniae is not solely due to vncS mutations. Erythromycin-induced tolerance in pneumococci arises from growth changes, not vncS inactivation.
Area of Science:
- Microbiology
- Molecular Biology
- Antibiotic Resistance
Background:
- Vancomycin tolerance in Streptococcus pneumoniae is an emerging challenge in drug-resistant pathogens.
- Previous models suggested mutations in VncRS or VexABC transporter contribute to tolerance.
Purpose of the Study:
- To investigate the role of vncS, vncR, vex3, and pep27 in vancomycin tolerance in Streptococcus pneumoniae.
- To test the hypothesis that vncS mutations prevent response to Pep27 signal, leading to tolerance.
Main Methods:
- Constructed isogenic mutants (DeltavncS, DeltavncR, Deltavex3, Deltapep27) in S. pneumoniae.
- Assessed lytic responses to vancomycin and other antibiotics.
- Investigated erythromycin-induced tolerance.
- Performed microarray transcriptional analysis and beta-galactosidase reporter assays.
Main Results:
- Mutants lacking vncS, vncR, vex3, or pep27 showed no difference in lytic response to vancomycin compared to the parent strain.
- DeltavncS strains did not exhibit vancomycin tolerance and remained sensitive to other antibiotics.
- Erythromycin exposure induced vancomycin tolerance in late-exponential phase, dependent on growth conditions, not vncS inactivation.
- Pep27 did not induce pneumococcal killing.
- VncS regulates the vex123 gene cluster, but VncRS is not involved in regulating autolytic or cell death loci.
Conclusions:
- Vancomycin tolerance in S. pneumoniae is not caused by vncS loss of function alone.
- Erythromycin-induced tolerance is a phenomenon linked to growth phase and other erythromycin-dependent factors.
- The VncRS system's role in vancomycin tolerance is likely indirect or not related to direct regulation of cell death pathways.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Antibiotic Selection
Regulation of Bacterial Virulence